Lesinurad is a selective urate transporter 1 (URAT1) inhibitor used in combination with xanthine oxidase inhibitors to treat hyperuricemia associated with gout. To ensure the safety and efficacy of this… Read more









Lesinurad is a selective urate transporter 1 (URAT1) inhibitor used in combination with xanthine oxidase inhibitors to treat hyperuricemia associated with gout. To ensure the safety and efficacy of this anti-gout medication, pharmaceutical laboratories rely on high-quality reference standards to support rigorous quality control and method validation. This category provides essential analytical tools, including the Lesinurad active pharmaceutical ingredient, its known impurities, and identified metabolites. These compounds are critical for impurity profiling and routine testing, enabling researchers to detect, quantify, and characterize potential degradants or synthesis byproducts in drug substance batches. By utilizing these precisely characterized reference standards and related derivatives, laboratories can maintain compliance with analytical protocols and ensure consistent pharmaceutical quality throughout the development and manufacturing lifecycle of the drug product.